24 /100
LOW RISK
Score updated May 28, 2026

MDGL — Madrigal Pharmaceuticals, Inc. Dilution Risk Tracker

Track MDGL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MDGL — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration 15%
• Score climbed 8 points (worsening)
🔔 Track MDGL — Get forecast alerts →

💹 Market Data

Market Cap$12.08B
Shares Outstanding23.06M
Float12.91M
Cash$227.03M
Debt$340.33M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 1.4% shares (2025Q4 vs prior)
393 institutional holders · 24.81M shares
#1 BAKER BROS. ADVISORS LP 2.14M shares
#2 RTW INVESTMENTS, LP 1.99M shares
#3 VANGUARD GROUP INC 1.81M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.85M
Days to Cover16.5
% of Float29.9%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2023
xbrl XBRL CONVERTIBLE May 09, 2022
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track MDGL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MDGL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for MDGL
📊 MDGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MDGL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.